Tag Archives: Cuts

Budget Cutters Propose Big Hits on Pharma

By Guest Blogger | Published: April 17, 2013
By Jill Wechsler, Washington Correspondent. The Obama administration’s budget plan for fiscal year 2014 apparently assumes that the pharmaceutical industry can support Medicare and other health programs through changes in drug coverage and payments. It also relies on industry fees to keep the Food and Drug Administration up and running. Meanwhile, FDA and other public health [...]
Posted in Guest Blog, Op-Ed, healthcare | Also tagged , , , , , , | Leave a comment

US Cuts Could Jeopardize Global Health Innovations, Says Report

By Julian Upton | Published: February 20, 2013
Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report by the Global Health Technologies Coalition.
Posted in Events | Also tagged , , , , | Leave a comment

Saving Greece's Healthcare System: A Harbinger for Europe?

By Reflector | Published: December 19, 2012
A just-published report from the European taskforce trying to help Greece crawl out of its crisis makes clear just how significant a role health reform is supposed to play in restoring health to the economy. It is, in a very acute form, a harbinger of what is around the corner for the other countries of [...]
Posted in Europe, Global, Guest Blog, healthcare | Also tagged , , , , , | Leave a comment

European Pharma Bets on Greek Salvation

By Guest Blogger | Published: November 19, 2012
The French philosopher Pascal calculated that it was better to believe in God than to disbelieve. After offering the country a €2.88 billion cap on drug spending, it looks like European pharma is taking that view with regard to Greece. Reflector reports. The European pharma industry looks like it is accepting Pascal’s Wager in Greece. It [...]
Posted in Europe, Global, Guest Blog | Also tagged , , , , , | Leave a comment

Spanish Generics Industry to Government: "Leave Branded Pharma Alone"

By Guest Blogger | Published: October 24, 2012
Just days before the reports that R&D investment in Spanish pharma had fallen to below EUR1 billion ($1.3 billion) in 2011 for the first time since 2007, the country’s generic manufacturers association, AESEG, offered some unexpected support for the branded industry. In comments to APM Health Europe described as “rare”, AESEG chief Ángel Luis Rodríguez de [...]
Posted in Europe, Global, healthcare | Also tagged , , , , , | Leave a comment